Sterility Clinical Trial
— PROMENIAOfficial title:
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist Following Two Protocols of Ovulation Induction for Intrauterine Insemination
To assess the effectiveness of protocols of ovarian hyperstimulation combining urinary
gonadotrophins + GnRH antagonist vs urinary gonadotrophins, to achieve clinical pregnancy in
females undergoing intrauterine insemination.
Study hypothesis: protocols combining urinary gonadotrophins + GnRH antagonist should be
more effective than monotherapy.
Status | Completed |
Enrollment | 131 |
Est. completion date | March 2009 |
Est. primary completion date | October 2008 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 36 Years |
Eligibility |
Inclusion Criteria: - Women aged 18-36 years - Body mass index (BMI) between 18 and 26 - Prolactin within the laboratory normal range - Couples affected by sterility able to treat by IUI (intrauterine insemination) - Patients undergoing Menopur® treatment - Normal thyroid function - Regular menses (21-35 days) - Couples willing to participate in the study that have signed the informed consent form - Seminal sample REM>3 million Exclusion Criteria: - Two previous ART (assisted reproductive technology) cycles without ongoing pregnancy - Policystic ovarian syndrome - Evidence of significant bacterial infection in the seminogram of the couple in the preceding 6 months |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Spain | Investigational site | Barcelona | |
Spain | Investigational site | Ciudad Real | |
Spain | Investigational site | Gerona | |
Spain | Investigational site | La Rioja | |
Spain | Investigational site | Navarra | |
Spain | Investigational site | Reus | Tarragona |
Spain | Investigational site | Valladolid |
Lead Sponsor | Collaborator |
---|---|
Ferring Pharmaceuticals | Ferring SAU |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical pregnancy rate | 30 days | No | |
Secondary | Live birth rate | 40 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01955356 -
Embryo Implantation After Induced Endometrial Injury
|
N/A | |
Completed |
NCT01330784 -
Assessment of the Therapeutic Utility of hMG-HP
|
N/A | |
Completed |
NCT01330771 -
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP
|
N/A | |
Active, not recruiting |
NCT05079685 -
HyFoSy Versus HSG as a Diagnostic Technique for Tubal Patency.
|
||
Completed |
NCT04605003 -
Effectiveness of Nasal Endoscope Sterilization Using a Novel Rig-S™ Device
|
N/A | |
Completed |
NCT02607319 -
Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure
|
Phase 4 | |
Completed |
NCT01331720 -
Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation
|
N/A | |
Not yet recruiting |
NCT02648555 -
A Lifestyle Intervention to Improve in Vitro Fertilization Results
|
N/A | |
Suspended |
NCT00749853 -
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
|
Phase 3 | |
Recruiting |
NCT03177122 -
Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology
|
Phase 4 | |
Completed |
NCT03169166 -
The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies
|
Phase 4 | |
Completed |
NCT01406964 -
Chlamidia Antibodies Test for Tubal Factor Screening
|
N/A | |
Completed |
NCT01430650 -
Endometrial Priming for Embryo Transfer
|
Phase 4 | |
Completed |
NCT03173404 -
Benefits of Hysteroscopy Prior to Performing a Cycle of in Vitro Fertilization/Intracytoplasmic Sperm Injection
|
N/A | |
Completed |
NCT03561129 -
Embryotransfer Operator and Pregnancy Rate
|
||
Recruiting |
NCT05173597 -
Real-world Evidence on Follitropin Delta Individual Dosing
|
||
Recruiting |
NCT04026282 -
To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment
|
N/A | |
Completed |
NCT03619707 -
Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer Cycles
|
Phase 4 |